Forside  

6 Referanser

Velg data du ønsker med i utskriften
Tittel Versjon Status
IS-nr
Revisjonsdato Publiseringsdato
Utgiver(e) Redaktør Publikasjonstype
  • Norsk tittel - Nasjonale retningslinjer for utredning, behandling og oppfølging av pasienter med Menières sykdom
  • Engelsk tittel -
  • Versjon - 2
  • Status - Publisert
  • IS-nr - 2527
  • ISBN -
  • DOI -
  • Revisjonsdato - 15.12.2016
  • Neste revisjon -
  • Publikasjonsdato - 21.11.2008
  • Utløpsdato -
  • Utgiver(e) - Helsedirektoratet
  • Redaktør - Frederik Goplen, Stein Helge Glad Nordahl, Per Møller
  • Publikasjonstype - Nasjonale retningslinjer
Vedlegg
 

1. Goebel JA. 2015 Equilibrium Committee Amendment to the 1995 AAO-HNS Guidelines for the Definition of Meniere's Disease. Otolaryngol Head Neck Surg 2016;154(3):403-4.
2. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandala M, et al. Criterios diagnosticos de enfermedad de Meniere. Documento de consenso de la Barany Society, la Japan Society for Equilibrium Research, la European Academy of Otology and Neurotology (EAONO), la American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) y la Korean Balance Society. Acta Otorrinolaringol Esp 2016;67(1):1-7.
3. Atkinson M. Meniere's original papers: Reprinted with an English translation together with commentaries and biographical sketch. Acta Otolaryngol Suppl 1961;(162).
4. Friberg U, Stahle J, Svedberg A. The natural course of Meniere's disease. Acta Otolaryngol Suppl 1984;406:72-7.
5. Schmidt PH, Brunsting RC, Antvelink JB. Meniere's disease: etiology and natural history. Acta Otolaryngol 1979;87(3-4):410-2.
6. Salt AN, Plontke SK. Endolymphatic hydrops: pathophysiology and experimental models. Otolaryngol Clin North Am 2010;43(5):971-83.
7. Chiarella G, Petrolo C, Cassandro E. The genetics of Meniere's disease. Appl Clin Genet 2015;8:9-17.
8. Gibson WP. Hypothetical mechanism for vertigo in Meniere's disease. Otolaryngol Clin North Am 2010;43(5):1019-27.
9. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113(3):181-5.
10. Shojaku H, Watanabe Y, Fujisaka M, Tsubota M, Kobayashi K, Yasumura S, et al. Epidemiologic characteristics of definite Meniere's disease in Japan. A long-term survey of Toyama and Niigata prefectures. ORL J Otorhinolaryngol Relat Spec 2005;67(5):305-9.
11. Kotimäki J, Sorri M, Aantaa E, Nuutinen J. Prevalence of Meniere disease in Finland. Laryngoscope 1999;109(5):748-53.
12. Harrison MS, Naftalin L. Natural history of Menière’s disease. I: Menière’s Disease. Springfield: C. C. Thomas; 1968. s. 13-27.
13. Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, Lempert T, et al. Screening for Meniere's disease in the general population - the needle in the haystack. Acta Otolaryngol 2008;128(3):272-6.
14. Celestino D, Ralli G. Incidence of Meniere's disease in Italy. Am J Otol 1991;12(2):135-8.
15. Wladislavosky-Waserman P, Facer GW, Mokri B, Kurland LT. Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980. Laryngoscope 1984;94(8):1098-102.
16. Havia M, Kentala E, Pyykko I. Prevalence of Meniere's disease in general population of Southern Finland. Otolaryngol Head Neck Surg 2005;133(5):762-8.
17. Neuhauser HK, von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005;65(6):898-904.
18. Perez-Garrigues H, Lopez-Escamez JA, Perez P, Sanz R, Orts M, Marco J, et al. Time course of episodes of definitive vertigo in Meniere's disease. Arch Otolaryngol Head Neck Surg 2008;134(11):1149-54.
19. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629-808.
20. Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS drugs 2003;17(2):85-100.
21. Santos PM, Hall RA, Snyder JM, Hughes LF, Dobie RA. Diuretic and diet effect on Meniere's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg 1993;109(4):680-9.
22. Klockhoff I, Lindblom U. Glycerol test in Meniere's disease. Acta Otolaryngol 1966;(Suppl 224):449-51.
23. Oz I, Erbek SH, Alp G, Hizal E, Ozluoglu LN. Glycerol affects vestibular-evoked myogenic potentials and pure-tone hearing in patients with Meniere's disease. Acta Otolaryngol 2015;135(2):111-8.
24. Thirlwall AS, Kundu S. Diuretics for Meniere's disease or syndrome. Cochrane Database Syst Rev 2006;(3):CD003599.
25. Crowson MG, Patki A, Tucci DL. A Systematic Review of Diuretics in the Medical Management of Meniere's Disease. Otolaryngol Head Neck Surg 2016;154(5):824-34.
26. Murdin L, Hussain K, Schilder AG. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev 2016;(6):CD010696.
27. Martinez DM. The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol Suppl 1972;305:29-47.
28. James AL, Burton MJ. Betahistine for Meniere's disease or syndrome. Cochrane Database Syst Rev 2001;(1):CD001873.
29. Schmidt JT, Huizing EH. The clinical drug trial in Meniere's disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl 1992;497:1-189.
30. Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K, et al. Long-term prophylactic treatment of attacks of vertigo in Meniere's disease--comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 2008;128(5):520-4.
31. Adrion C, Fischer CS, Wagner J, Gurkov R, Mansmann U, Strupp M. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 2016;352:h6816.
32. Hanner P, Rask-Andersen H, Lange S, Jennische E. Antisecretory factor-inducing therapy improves the clinical outcome in patients with Meniere's disease. Acta Otolaryngol 2010;130(2):223-7.
33. Leong SC, Narayan S, Lesser TH. Antisecretory factor-inducing therapy improves patient-reported functional levels in Meniere's disease. Ann Otol Rhinol Laryngol 2013;122(10):619-24.
34. Godemann F, Schabowska A, Naetebusch B, Heinz A, Strohle A. The impact of cognitions on the development of panic and somatoform disorders: a prospective study in patients with vestibular neuritis. Psychol Med 2006;36(1):99-108.
35. Holmberg J, Karlberg M, Harlacher U, Magnusson M. One-year follow-up of cognitive behavioral therapy for phobic postural vertigo. J Neurol 2007;254(9):1189-92.
36. Staab JP, Ruckenstein MJ. Expanding the differential diagnosis of chronic dizziness. Arch Otolaryngol Head Neck Surg 2007;133(2):170-6.
37. Montandon P, Guillemin P, Häusler R. Prevention of vertigo in Meniere's syndrome by means of transtympanic ventilation tubes. ORL J Otorhinolaryngol Relat Spec 1988;50(6):377-81.
38. Park JJ, Chen YS, Westhofen M. Meniere's disease and middle ear pressure: vestibular function after transtympanic tube placement. Acta Otolaryngol 2009;129(12):1408-13.
39. Sugawara K, Kitamura K, Ishida T, Sejima T. Insertion of tympanic ventilation tubes as a treating modality for patients with Meniere's disease: a short- and long-term follow-up study in seven cases. Auris Nasus Larynx 2003;30(1):25-8.
40. van Sonsbeek S, Pullens B, van Benthem PP. Positive pressure therapy for Meniere's disease or syndrome. Cochrane Database Syst Rev 2015;(3):CD008419.
41. Portmann G. The saccus endolymphaticus and an operation for draining the same for the relief of vertigo. J Laryngol Otol 1972;42(12):809-17.
42. Huang TS. Endolymphatic sac surgery for Meniere's disease: experience with over 3000 cases. Otolaryngol Clin North Am 2002;35(3):591-606.
43. Møller P. Kirurgisk behandling av Menieres sykdom. Tidsskr Nor Legeforen 2003;123(9):1184-6.
44. Jackson CG, Dickins JR, McMenomey SO, Graham SS, Glasscock ME, 3rd, Minor LB, et al. Endolymphatic system shunting: a long-term profile of the Denver Inner Ear Shunt. Am J Otol 1996;17(1):85-8.
45. Thomsen J, Bretlau P, Tos M, Johnsen NJ. Placebo effect in surgery for Meniere's disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 1981;107(5):271-7.
46. Thomsen J, Bonding P, Becker B, Stage J, Tos M. The non-specific effect of endolymphatic sac surgery in treatment of Meniere's disease: a prospective, randomized controlled study comparing "classic" endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol 1998;118(6):769-73.
47. Welling DB, Nagaraja HN. Endolymphatic mastoid shunt: a reevaluation of efficacy. Otolaryngol Head Neck Surg 2000;122(3):340-5.
48. Pullens B, Verschuur HP, van Benthem PP. Surgery for Meniere's disease. Cochrane Database Syst Rev 2013;(2):CD005395.
49. Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005;133(2):285-94.
50. Phillips JS, Westerberg B. Intratympanic steroids for Meniere's disease or syndrome. Cochrane Database Syst Rev 2011;(7):CD008514.
51. Casani AP, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 2012;146(3):430-7.
52. Gabra N, Saliba I. The effect of intratympanic methylprednisolone and gentamicin injection on Meniere's disease. Otolaryngol Head Neck Surg 2013;148(4):642-7.
53. Lambert PR, Nguyen S, Maxwell KS, Tucci DL, Lustig LR, Fletcher M, et al. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Meniere's disease. Otol Neurotol 2012;33(7):1257-65.
54. Shapira Y, Telischi FF. Tympanic membrane breakdown after intratympanic injection of steroids in irradiated ears. Otol Neurotol 2007;28(4):499-500.
55. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004;25(4):544-52.
56. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Meniere's disease: a meta-analysis. Laryngoscope 2004;114(12):2085-91.
57. Diamond C, O'Connell DA, Hornig JD, Liu R. Systematic review of intratympanic gentamicin in Meniere's disease. J Otolaryngol 2003;32(6):351-61.
58. Pullens B, van Benthem PP. Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev 2011;(3):CD008234.
59. Stokroos R, Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Meniere's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol 2004;124(2):172-5.
60. Huon LK, Fang TY, Wang PC. Outcomes of intratympanic gentamicin injection to treat Meniere's disease. Otol Neurotol 2012;33(5):706-14.
61. Casano RA, Johnson DF, Bykhovskaya Y, Torricelli F, Bigozzi M, Fischel-Ghodsian N. Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am J Otolaryngol 1999;20(3):151-6.
62. Benecke JE, Jr., Tubergen LB, Miyamoto RT. Transmastoid labyrinthectomy. Am J Otol 1986;7(1):41-3.
63. De La Cruz A, Borne Teufert K, Berliner KI. Transmastoid labyrinthectomy versus translabyrinthine vestibular nerve section: does cutting the vestibular nerve make a difference in outcome? Otol Neurotol 2007;28(6):801-8.
64. Diaz RC, LaRouere MJ, Bojrab DI, Zappia JJ, Sargent EW, Shaia WT. Quality-of-life assessment of Meniere's disease patients after surgical labyrinthectomy. Otol Neurotol 2007;28(1):74-86.
65. Kaylie DM, Jackson CG, Gardner EK. Surgical management of Meniere's disease in the era of gentamicin. Otolaryngol Head Neck Surg 2005;132(3):443-50.
66. Langman AW, Lindeman RC. Surgical labyrinthectomy in the older patient. Otolaryngol Head Neck Surg 1998;118(6):739-42.
67. Levine SC, Glasscock M, McKennan KX. Long-term results of labyrinthectomy. Laryngoscope 1990;100(2 Pt 1):125-7.
68. Heywood RL, Atlas MD. Simultaneous cochlear implantation and labyrinthectomy for advanced Meniere's disease. J Laryngol Otol 2016;130(2):204-6.
69. Colletti V, Carner M, Colletti L. Auditory results after vestibular nerve section and intratympanic gentamicin for Meniere's disease. Otol Neurotol 2007;28(2):145-51.
70. Hillman TA, Chen DA, Arriaga MA. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease. Laryngoscope 2004;114(2):216-22.
71. Schlegel M, Vibert D, Ott SR, Häusler R, Caversaccio MD. Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Meniere's disease. Otol Neurotol 2012;33(8):1380-5.
72. Silverstein H, Jackson LE. Vestibular nerve section. Otolaryngol Clin North Am 2002;35(3):655-73.